TS Financial Group (TSFG)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
200
| – | – | ﹤0.01% | 524 |
|
|
2025
Q1 | $13K | Hold |
200
| – | – | ﹤0.01% | 509 |
|
|
2024
Q4 | $13K | Hold |
200
| – | – | ﹤0.01% | 462 |
|
|
2024
Q3 | $14K | Hold |
200
| – | – | ﹤0.01% | 453 |
|
|
2024
Q2 | $13K | Hold |
200
| – | – | ﹤0.01% | 447 |
|
|
2024
Q1 | $13K | Hold |
200
| – | – | ﹤0.01% | 447 |
|
|
2023
Q4 | $13K | Hold |
200
| – | – | ﹤0.01% | 475 |
|
|
2023
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 515 |
|
|
2023
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 507 |
|
|
2023
Q1 | $13K | Hold |
200
| – | – | ﹤0.01% | 486 |
|
|
2022
Q4 | $13K | Hold |
200
| – | – | 0.01% | 486 |
|
|
2022
Q3 | $12K | Hold |
200
| – | – | 0.01% | 484 |
|
|
2022
Q2 | $12K | Hold |
200
| – | – | 0.01% | 497 |
|
|
2022
Q1 | $12K | Hold |
200
| – | – | ﹤0.01% | 519 |
|
|
2021
Q4 | $14K | Hold |
200
| – | – | ﹤0.01% | 504 |
|
|
2021
Q3 | $15K | Hold |
200
| – | – | 0.01% | 484 |
|
|
2021
Q2 | $15K | Hold |
200
| – | – | 0.01% | 482 |
|
|
2021
Q1 | $15K | Hold |
200
| – | – | 0.01% | 417 |
|
|
2020
Q4 | $14K | Hold |
200
| – | – | 0.01% | 433 |
|
|
2020
Q3 | $11K | Hold |
200
| – | – | 0.01% | 423 |
|
|
2020
Q2 | $12K | Hold |
200
| – | – | 0.01% | 396 |
|
|
2020
Q1 | $9K | Buy |
+200
| New | +$9K | 0.01% | 403 |
|